@article{f6a144ecf5a44f96b75c099f648ef804,
title = "Combining biological therapies in patients with inflammatory bowel disease: a Finnish multi-centre study",
keywords = "Inflammatory bowel disease, dual biological therapy, combining biological therapies, adalimumab, golimumab, vedolizumab, ustekinumab, EVIDENCE-BASED CONSENSUS, CROHNS-DISEASE, ULCERATIVE-COLITIS, CLINICAL-COURSE, VEDOLIZUMAB, MANAGEMENT, DIAGNOSIS, SAFETY, 3121 General medicine, internal medicine and other clinical medicine",
author = "Heli Eronen and Sara Kolehmainen and Jukka Koffert and Inka Koskinen and Pia Oksanen and Airi Jussila and Heini Huhtala and Taina Sipponen and Tuire Ilus",
year = "2022",
month = aug,
day = "3",
doi = "10.1080/00365521.2022.2045350",
language = "English",
volume = "57",
pages = "936--941",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Taylor and Francis Ltd.",
number = "8",
}